Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.95%
#2 clBTC clBTC +12.15%
#3 OpenEden OpenEden +11.48%
#4 BasedHype BasedHype +11.14%
#5 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.73%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +8.41%
#7 Mantle Staked Ether Mantle Staked Ether +8.34%
#8 Mantle Restaked ETH Mantle Restaked ETH +8.01%
#9 MarsCoin MarsCoin +6.65%
#10 EfficientFrontier EfficientFrontier +4.93%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Mushrooms Inc. Mushrooms Inc.

Mushrooms Inc.

MSRM
Rangering i aksjer #40133
Mushrooms, Inc. is a biotechnology company that develops products from... Mushrooms, Inc. is a biotechnology company that develops products from mushrooms and mycelium. The company focuses on mycelium's industrial applications for carbon-neutral products, health supplements, and technologies for healthcare and textiles, such as bacterial detection and nutrient delivery. The company was formerly known as Marijuana Strategic Ventures Inc. and changed its name to Mushrooms Inc. in October 2022. [20, 22, 28, 33]
Aksjekurs
$0.0141
Sist synkronisert: 2026-08-12
Markedsverdi
$236.75K
Endring (1 dag)
0.00%
Endring (1 år)
-25.79%
Land
US
Handel Mushrooms Inc. (MSRM)

Kategori

Healthcare
Inntekter for Mushrooms Inc. (MSRM)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Mushrooms Inc. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Mushrooms Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE